-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Written by—Jiang Li, Guo Jifeng
Editor-in-charge - Wang SizhenEditor—Summer Leaf
Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive decline in memory and cognitive function as the main clinical manifestations
.
In recent years, the concept of the "gut-brain axis" has received great attention from the academic community, that is, there is a two-way information exchange between the intestine and the central nervous system, and more and more evidence shows that the dysfunction of the "gut-brain axis" is related to the occurrence of a variety of gastrointestinal diseases and central nervous system diseases [1].
。 In January 2021, Gut published a report by Zhang et al.
on inflammatory bowel disease ( Inflammatoryboweldisease (IBD) and dementia, the study used 1742 IBD patients in Taiwan to relate to A comparison of 17,420 control groups found that patients with IBD had a 2.
54-fold higher risk of dementia after diagnosis than those without IBD, including AD The risk is highest for two subtypes of IBD — ulcerative colitis (UC) and crohn's disease , CD) – increased risk of dementia with no clear difference [2].
However, since traditional observational studies are susceptible to residual confounders (caused by measurement errors and unknown confounders) and reverse causal bias, which can only suggest one correlation, causal inferences from these findings require further evaluation
.
Recently, the team of Professor Guo Jifeng of Xiangya Hospital of Central South University published a title in the international top journal "Gut" (IF: 31.
793).
Research paper "Association between inflammatory bowel disease and Alzheimer's disease: multivariable and bidirectional Mendelian randomisationanalyses.
"
。 The study explored IBD and its subtypes using the Mendelian randomization method (Mendelianrandomisatio n, MR).
UC and CD) and AD bidirectional causality
.
Professor Guo Jifeng of the Department of Neurology, Xiangya Hospital, Central South University, is the corresponding author of the paper, doctoral student Jiang Li is the first author of the paper, Professor Tang Beisha and Professor Shen Lu and Professor Li Jinchen of Xiangya Hospital of Central South University are important participating authors of the paper, and Xiangya Hospital of Central South University is the
first signature of the paper.
In this study, the authors found no strong evidence to support a causal relationship between IBD and its subtypes and AD, however, the authors found that AD may reduce UC New evidence of onset risk, further research based on this result will help reveal the pathogenesis of UC and may also provide new ideas
for drugs to treat UC.
The authors utilized published genome-wide association studies (GWAS) data related to IBD and its subtypes (UC and CD) and AD GWAS data, two-sample MR studies were carried out to explore the bidirectional causal relationship
between IBD, its subtypes and AD.
The GWAS data for IBD and its subtypes here come from Liu et al.
[3] and deLange, respectively the results of the GWAS study by et al.
[4]; Due to the late age of onset of AD, the GWAS dataset for AD typically includes older clinically diagnosed patients, and selective survival of IBD The competitive risk of AD may lead to selection bias, i.
e.
, the life expectancy of patients with IBD may be reduced by the onset of cardiovascular disease [5], and participants with IBD who die from cardiovascular disease may not be recruited In the GWAS study of AD, the MR estimates leading to harmful exposures may be weakened or even reversed to avoid the effect of selective survival bias on MR results, The authors used the GWAS dataset for clinical diagnosis of AD (21,982 patients and 41,944 controls) as the primary dataset[6] , another GWAS data based on AD surrogate cases (314278 cases) from the UK Biobank [7].
and data from a larger meta-analysis of GWAS in clinically diagnosed AD/AD surrogate cases (71,880 patients and 383378 controls).
[8] As a secondary dataset, participants in AD surrogate cases are less susceptible to selective survival bias due to their relatively young age
.
At the same time, due to the high degree of overlap of genetic instrumental variables between UC and CD, the authors used a multivariate MR approach to analyze UC and CD Independent causal effects
on AD.
Flow chart of the selection process of genetic instrument variables for IBD (UC and CD) (Source: Li, Jiang, etal.
, Gut, 2022).
The results showed that IBD could reduce the risk of AD in the dataset of clinical diagnosis of AD (IVW: OR=0.
97, 95%CI:0.
94-0.
99; P=0.
046), but the results were not significant in the AD surrogate case dataset, and the results in the dataset of the clinical diagnosis AD/AD surrogate case meta-analysis were still not significant.
The multivariate MR results did not show a significant causal association
between UC, CD and AD.
In the reverse MR study, the authors found that genetically determined susceptibility to AD reduced the risk of UC (IVW: OR=0.
91, 95% CI: 0.
84-0.
99; P=0.
025), but the causal relationship between AD and IBD and CD was not significant
.
Sensitivity analyses showed that the study was not affected by heterogeneity and levels of pleiotropy, so the results were relatively robust
.
OR estimates and 95% CIs for bidirectional causal association between IBD (UC and CD) and AD (Source: Li, Jiang, etal.
, Gut, 2022) Conclusion and discussion, inspiration and prospect
Taken together, the authors used Mendelian randomization methods to find no strong evidence to support inflammatory bowel disease ( IBD) and Alzheimer's disease (AD), associations observed in previous epidemiological studies should not be considered causal
.
The protective association between IBD and AD observed in this study may be a selective survival bias due to the use of clinically diagnosed cases of relatively older age, and while the authors cannot completely rule out negative results due to the use of less precise AD proxy cases, this divergence warrants further investigation
.
The new findings of this study regarding the causal relationship between AD and IBD subtype ulcerative colitis are too wide and require future studies with larger sample sizes to validate and improve the precision of
the results.
Original link: https://gut.
bmj.
com/content/early/2022/09/07/gutjnl-2022-327860
Corresponding author: Guo Jifeng (left); First author: Jiang Li (right).
(Photo courtesy of Guo Jifeng Laboratory)
About the corresponding author:
Jifeng Guo, researcher, associate professor, doctoral supervisor
.
Director of
the Department of Neurology, Xiangya Hospital, Central South University, Department of Neurodegenerative Diseases and Genetic Diseases.
He has presided over 2 sub-projects of the National Key R&D Program, 5 projects of the National Natural Science Foundation of China, 1 project of Hunan Outstanding Youth Fund, and participated in 973 projects and 863 10 projects, such as the National Natural Science Foundation of China, in Brain, PNAS, MolNeurodegener, etc Neurology, MovDisord and other foreign core journals have published more than 90 papers as the first author or corresponding author
.
[1] J Neurosci-Hu Bo's research group revealed the role of dorsal hippocampal small albumin-positive interneurons in joint motor learning and their network activity mechanism
[2] CNSNT—Gu Xiaoping's team revealed that enhancing astrocyte networks can improve brain network abnormalities and cognitive dysfunction caused by long-term isoflurane anesthesia
[3] Nat Aging—Glial cells in mouse with Alzheimer's disease are involved in synaptic clearance through the complement pathway
[4] J Neuroinflammation—Chen Gang's research group revealed that Schwann cell Pannexin 1 regulates neuropathic pain by mediating inflammatory responses
[5] NPP-Luo Xiongjian's research group uses Mendelian randomization to screen potential drug targets for the treatment of mental illness
[6] Adv SCI-Chai Renjie's team has made important progress in the regeneration of functional hair cells of cochlear organoids
[7] J Neuroinflammation—Tang Yamei's team discovered the mechanism by which pregabalin mitigates microglial activation and neuronal damage in radiation brain injury
[8] Transl Psychiatry—Accelerated aging of brain function in patients with major depression: evidence from large Chinese participants
[9] Nat Commun-Xu Tianle/Li Weiguang/Zhang Siyu teamwork to reveal the neuronal cluster organization law of fear and fading memory competition
[10] Brain-Yi Chenju/Niu Jianqin's team found that activating the Wnt/β-catenin pathway can alleviate blood-brain barrier dysfunction in Alzheimer's disease
Recommended high-quality scientific research training courses[1] Symposium on Single Cell Sequencing and Spatial Transcriptomics Data Analysis (October 29-30, Tencent Online Conference)[2] Symposium on Patch-clamping and Optogenetics and Calcium Imaging Technology (October 15-16, 2022 Tencent Conference) Conference/Forum Preview & Review[1] Preview | Neuromodulation and Brain-Computer Interface Conference (October 13-14, Beijing time) (U.
S.
Pacific Time: October 12-13)
[2] Conference report - The human brain and the machine are gradually getting closer, and the brain-computer interface "black technology" is shining into reality
reference literature (Swipe up and down to read).
[1] OsadchiyV, Martin CR, Mayer EA.
The Gut-Brain Axis and the Microbiome:Mechanisms and Clinical Implications.
Clin Gastroenterol Hepatol.
2019.
17(2): 322-332.
[2] ZhangB, Wang HE, Bai YM, et al.
Inflammatory bowel disease is associatedwith higher dementia risk: a nationwide longitudinal study.
Gut.
2020.
[3] LiuJZ, van Sommeren S, Huang H, et al.
Association analyses identify 38susceptibility loci for inflammatory bowel disease and highlightshared genetic risk across populations.
Nat Genet.
2015.
47(9):979-986.
[4] deLange KM, Moutsianas L, Lee JC, et al.
Genome-wide association studyimplicates immune activation of multiple integrin genes ininflammatory bowel disease.
Nat Genet.
2017.
49(2): 256-261.
[5] ArgolloM, Gilardi D, Peyrin-Biroulet C, Chabot JF, Peyrin-Biroulet L, DaneseS.
Comorbidities in inflammatory bowel disease: a call for action.
Lancet Gastroenterol Hepatol.
2019.
4(8): 643-654.
[6] KunkleBW, Grenier-Boley B, Sims R, et al.
Genetic meta-analysis ofdiagnosed Alzheimer's disease identifies new risk loci and implicatesAβ, tau, immunity and lipid processing.
Nat Genet.
2019.
51(3):414-430.
[7] MarioniRE, Harris SE, Zhang Q, et al.
GWAS on family history of Alzheimer'sdisease.
Transl Psychiatry.
2018.
8(1): 99.
[8] JansenIE, Savage JE, Watanabe K, et al.
Genome-wide meta-analysisidentifies new loci and functional pathways influencing Alzheimer'sdisease risk.
Nat Genet.
2019.
51(3): 404-413
End of this article